These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 38849023)
1. Carbon dots as dual inhibitors of tau and amyloid-beta aggregation for the treatment of Alzheimer's disease. Zhang W; Smith N; Zhou Y; McGee CM; Bartoli M; Fu S; Chen J; Domena JB; Joji A; Burr H; Lv G; Cilingir EK; Bedendo S; Claure ML; Tagliaferro A; Eliezer D; Veliz EA; Zhang F; Wang C; Leblanc RM Acta Biomater; 2024 Jul; 183():341-355. PubMed ID: 38849023 [TBL] [Abstract][Full Text] [Related]
2. Drug delivery of memantine with carbon dots for Alzheimer's disease: blood-brain barrier penetration and inhibition of tau aggregation. Zhang W; Kandel N; Zhou Y; Smith N; C L B Ferreira B; Perez M; Claure ML; Mintz KJ; Wang C; Leblanc RM J Colloid Interface Sci; 2022 Jul; 617():20-31. PubMed ID: 35255395 [TBL] [Abstract][Full Text] [Related]
3. Nontoxic amphiphilic carbon dots as promising drug nanocarriers across the blood-brain barrier and inhibitors of β-amyloid. Zhou Y; Liyanage PY; Devadoss D; Rios Guevara LR; Cheng L; Graham RM; Chand HS; Al-Youbi AO; Bashammakh AS; El-Shahawi MS; Leblanc RM Nanoscale; 2019 Nov; 11(46):22387-22397. PubMed ID: 31730144 [TBL] [Abstract][Full Text] [Related]
4. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease. Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603 [TBL] [Abstract][Full Text] [Related]
5. Quercetin-derived red emission carbon dots: A multifunctional theranostic nano-agent against Alzheimer's β-amyloid fibrillogenesis. Wei Z; Dong X; Sun Y Colloids Surf B Biointerfaces; 2024 Jun; 238():113907. PubMed ID: 38608464 [TBL] [Abstract][Full Text] [Related]
6. Thiophene-Based Dual Modulators of Aβ and Tau Aggregation. Ramesh M; Acharya A; Murugan NA; Ila H; Govindaraju T Chembiochem; 2021 Dec; 22(23):3348-3357. PubMed ID: 34546619 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of Halogen-Substituted novel α-Ketoamides as potential protein aggregation modulators in Alzheimer's disease. Das B; Tk Baidya A; Chakrabarti S; Chouhan D; Thakur B; Darreh-Shori T; Chen G; Tiwari V; Kumar R Bioorg Chem; 2024 Jun; 147():107373. PubMed ID: 38653149 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of 1,2,3,4-tetrahydro-1-acridone analogues as potential dual inhibitors for amyloid-beta and tau aggregation. Lv P; Xia CL; Wang N; Liu ZQ; Huang ZS; Huang SL Bioorg Med Chem; 2018 Sep; 26(16):4693-4705. PubMed ID: 30107970 [TBL] [Abstract][Full Text] [Related]
9. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain]. Watanabe H Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372 [TBL] [Abstract][Full Text] [Related]
10. In Silico Drug Design and Analysis of Dual Amyloid-Beta and Tau Protein-Aggregation Inhibitors for Alzheimer's Disease Treatment. Job N; Thimmakondu VS; Thirumoorthy K Molecules; 2023 Feb; 28(3):. PubMed ID: 36771052 [TBL] [Abstract][Full Text] [Related]
11. Binding of proteases to fibrillar amyloid-beta protein and its inhibition by Congo red. Chander H; Chauhan A; Chauhan V J Alzheimers Dis; 2007 Nov; 12(3):261-9. PubMed ID: 18057560 [TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of curcumin derivatives as tau and amyloid β dual aggregation inhibitors. Okuda M; Hijikuro I; Fujita Y; Teruya T; Kawakami H; Takahashi T; Sugimoto H Bioorg Med Chem Lett; 2016 Oct; 26(20):5024-5028. PubMed ID: 27624076 [TBL] [Abstract][Full Text] [Related]
13. Graphene quantum dots for the inhibition of β amyloid aggregation. Liu Y; Xu LP; Dai W; Dong H; Wen Y; Zhang X Nanoscale; 2015 Dec; 7(45):19060-5. PubMed ID: 26515666 [TBL] [Abstract][Full Text] [Related]
14. Exploring the potential of pyrazoline containing molecules as Aβ aggregation inhibitors in Alzheimer's disease. Khambete MP; Khare LP; Kapadia AB; Degani MS Drug Metab Pers Ther; 2020 Aug; 35(3):. PubMed ID: 32776895 [TBL] [Abstract][Full Text] [Related]
15. Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation. Ashrafian H; Zadeh EH; Khan RH Int J Biol Macromol; 2021 Jan; 167():382-394. PubMed ID: 33278431 [TBL] [Abstract][Full Text] [Related]
16. Identification of ortho catechol-containing isoflavone as a privileged scaffold that directly prevents the aggregation of both amyloid β plaques and tau-mediated neurofibrillary tangles and its in vivo evaluation. Son SH; Do JM; Yoo JN; Lee HW; Kim NK; Yoo HS; Gee MS; Kim JH; Seong JH; Inn KS; Seo MD; Lee JK; Kim NJ Bioorg Chem; 2021 Aug; 113():105022. PubMed ID: 34098397 [TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin gallate-derived carbonized polymer dots: A multifunctional scavenger targeting Alzheimer's β-amyloid plaques. Lin X; Liu W; Dong X; Sun Y Acta Biomater; 2023 Feb; 157():524-537. PubMed ID: 36503076 [TBL] [Abstract][Full Text] [Related]
18. Curcumin-derived carbon quantum dots: Dual actions in mitigating tau hyperphosphorylation and amyloid beta aggregation. Lim JL; Lin CJ; Huang CC; Chang LC Colloids Surf B Biointerfaces; 2024 Feb; 234():113676. PubMed ID: 38056413 [TBL] [Abstract][Full Text] [Related]
19. Multifunctional Selenium Quantum Dots for the Treatment of Alzheimer's Disease by Reducing Aβ-Neurotoxicity and Oxidative Stress and Alleviate Neuroinflammation. Guo X; Lie Q; Liu Y; Jia Z; Gong Y; Yuan X; Liu J ACS Appl Mater Interfaces; 2021 Jul; 13(26):30261-30273. PubMed ID: 34169710 [TBL] [Abstract][Full Text] [Related]
20. Amyloid-β and tau aggregation dual-inhibitors: A synthetic and structure-activity relationship focused review. Malafaia D; Albuquerque HMT; Silva AMS Eur J Med Chem; 2021 Mar; 214():113209. PubMed ID: 33548635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]